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Summary
Background: Dietary restriction (DR) is the most effec-
tive environmental intervention to extend lifespan in
a wide range of species. However, the molecular mech-
anisms underlying the benefits of DR on longevity are
still poorly characterized. AMP-activated protein kinase
(AMPK) is activated by a decrease in energy levels, rais-
ing the possibility that AMPK might mediate lifespan
extension by DR.
Results: By using a novel DR assay that we developed
and validated in C. elegans, we find that AMPK is re-
quired for this DR method to extend lifespan and delay
age-dependent decline. We find that AMPK exerts its ef-
fects in part via the FOXO transcription factor DAF-16.
FOXO/DAF-16 is necessary for the beneficial effects
of this DR method on lifespan. Expression of an active
version of AMPK in worms increases stress resistance
and extends longevity in a FOXO/DAF-16-dependent
manner. Lastly, we find that AMPK activates FOXO/
DAF-16-dependent transcription and phosphorylates
FOXO/DAF-16 at previously unidentified sites, suggest-
ing a possible direct mechanism of regulation of FOXO/
DAF-16 by AMPK.
Conclusions: Our study shows that an energy-sensing
AMPK-FOXO pathway mediates the lifespan extension
induced by a novel method of dietary restriction in
C. elegans.
Introduction
Dietary restriction (DR)—restriction in food intake with-
out malnutrition—increases both the mean and maximal
lifespan in a wide range of species [1]. The longevity ef-
fects of DR are conserved in worms, flies, mice, and
possibly primates, underscoring the importance of this
environmental intervention on lifespan. In humans, DR
decreases the incidence of age-dependent diseases,
including atherosclerosis and cancer [2, 3]. Although nu-
merous hypotheses have been proposed to explain the
benefits of DR on longevity [4], the exact mechanisms by
*Correspondence: anne.brunet@stanford.eduwhich DR increases lifespan are still unclear. DR de-
creases available nutrients [5], raising the possibility
that nutrient-sensing pathways may mediate DR’s ben-
eficial effects on aging and age-dependent diseases.
The energy-sensing AMP-activated protein kinase
(AMPK) is an attractive candidate to mediate DR’s ability
to prolong lifespan. AMPK is activated in response to
decreased energy or glucose levels, which are conse-
quences of DR [6], and in specific cases, by DR itself
[7]. AMPK is a heterotrimeric protein kinase composed
of a catalytic subunit (a) and two regulatory subunits (b
and g) that sense low cellular energy levels by monitor-
ing changes in the AMP:ATP ratio [8]. AMP binding to
the g subunit induces a conformational change that al-
lows the catalytic a subunit to be phosphorylated and
activated by the AMPK-activating protein kinases
LKB1 and CAMKKb [9–13]. AMP also contributes to
AMPK activation by reducing the dephosphorylation of
the catalytic a subunit [14]. AMPK coordinates the adap-
tation of cellular metabolism and growth to decreased
energy levels [6]. One of the two a catalytic subunits of
AMPK (AMPKa2 or AAK-2) has recently been found to
increase worm longevity [15]. However, AAK-2 is not
necessary for longevity extension in response to a muta-
tion in the eat-2 gene [16], a mutation that is thought to
genetically mimic DR but might have pleiotropic effects.
Therefore, whether AMPK mediates lifespan extension
by DR is still unknown and the molecular mechanisms
by which AMPK controls lifespan remain unclear.
FOXO transcription factors are good candidates to
mediate AMPK’s ability to extend lifespan. These tran-
scriptional regulators play an important conserved role
in stress resistance by upregulating a series of target
genes, including genes involved in detoxification of re-
active oxygen species (ROS) [17–21]. FOXO factors are
also activated in response to decreased activity of the
insulin signaling pathway, an alternate nutrient-sensing
pathway in cells [22, 23]. In C. elegans, the FOXO tran-
scription factor DAF-16 mediates the longevity exten-
sion resulting from a mutation in the insulin receptor
daf-2 [17, 18]. Although the lifespan extension resulting
from the eat-2 mutation and to several DR regimens
has been shown to be independent of FOXO/DAF-16
[24–29], FOXO may still mediate lifespan extension
under other DR experimental conditions.
Based on these observations, we hypothesized that
AMPK and FOXO may be important mediators of the
beneficial effects of DR on longevity. By using a novel
method of DR in worms, we show that AMPK and
FOXO/DAF-16 are necessary to mediate a large part of
the lifespan extension in response to DR. In addition,
we show that constitutively active AMPK increases
worm stress resistance and longevity in a FOXO/DAF-
16-dependent manner. Lastly, we find that FOXO/
DAF-16 is a direct in vitro substrate of AMPK and that
AMPK increases FOXO-dependent transcription. To-
gether, these results place the AMPK-FOXO module as
a central pathway in the regulation of lifespan by DR.
An AMPK-FOXO Pathway Mediates DR-Induced Longevity
1647Results
Development of a New DR Method, sDR,
in the Nematode C. elegans
We developed a new DR method in worms by transfer-
ring adult worms every 2 days onto freshly seeded
plates with restrictive amounts of feeding bacteria
(from 5 3 1011 to 5 3 108 bacteria/ml) at day 4 of adult-
hood (Figure 1A). We verified that worms ingested fewer
bacteria under these conditions by using bacteria
expressing the red fluorescent reporter dsRed (Fig-
ure 1B). This restriction in bacterial intake significantly
increased worm lifespan (Figure 1C; Table S1 in the Sup-
plemental Data available online) and reduced worm
mortality rate (Figure 1D), indicating that this regimen
delays aging. Our regimen also increased resistance to
the oxidative stress agent Paraquat (Figure 1E; Table
S2A) and delayed the age-dependent decline in worm
locomotor activity (Figure 1F), consistent with the
reported ability of DR to delay aging and age-related
phenotypes in a variety of organisms [1]. The increase
in lifespan was not simply a result of reduced pathoge-
nicity or toxicity of the bacteria because (1) an increase
in bacterial concentration to 53 1012 bacteria/ml did not
shorten worm lifespan (Figure 1C) and (2) dilution of UV-
killed bacteria also extended worm lifespan, albeit to
a lesser extent (Figure 1G; Table S2B). Taken together,
these results indicate that the food-restriction regimen
that we have developed in C. elegans increases lifespan
in a manner that is similar to DR in other species. In the
rest of the manuscript, ad libitum will be 53 1011 bacte-
ria/ml and dietary restriction will be 53 108 bacteria/ml.
We will refer to this method as sDR for ‘‘solid DR,’’ as,
contrary to other methods, the diluted bacteria are
placed on solid plates.
sDR Increases the AMP:ATP Ratio and Is Dependent
on AMPK
Because AMPK is activated by low energy levels, we
asked whether sDR’s ability to extend lifespan was
mediated by AMPK in C. elegans. We first examined
whether the sDR regimen affected energy levels in
worms by measuring the AMP:ATP ratio in worm ex-
tracts by using reverse-phase high-performance liquid
chromatography (HPLC). We found that restricting the
amount of seeded bacteria from 5 3 1011 bacteria/ml
(ad libitum) to 53 108 bacteria/ml (sDR) at day 4 of adult-
hood significantly increased the AMP:ATP ratio in
worms (Figure 2A). These results indicate that sDR leads
to decreased energy levels in worms, as expected for
a diet that restricts available nutrients.
To determine whether AMPK mediated the ability of
sDR to extend lifespan in worms, we used a worm strain
carrying a deletion in the gene encoding one of the
catalytic subunits of AMPK (AMPK a2 or aak-2). The life-
span extension resulting from sDR was suppressed in
the aak-2 mutant (Figure 2B; Table S3), indicating that
AMPK is necessary for the lifespan extension resulting
from sDR. In addition, aak-2 was also necessary for sDR
to prevent the age-dependent decline in worm locomo-
tor activity (Figure 2C). Together, these data show that
AMPK is necessary for sDR to extend lifespan and to
slow age-dependent decline.The FOXO Transcription Factor DAF-16 Mediates
sDR-Induced Extension of Lifespan
Although FOXO transcription factors are attractive
candidates to mediate the actions of environmental in-
terventions controlling stress resistance and longevity,
several alternate methods of DR in worms have been
shown to be independent of FOXO/DAF-16 [24–29]. To
test whether DAF-16 played a role in lifespan extension
in response to sDR, we assessed the lifespan of wild-
type or daf-16 mutant worms in ad libitum or food-
restriction conditions. We found that the ability of sDR
to extend worm lifespan was diminished in daf-16 mu-
tants (Figure 3A; Table S4A). These results indicate
that DAF-16, like AMPK, mediates a portion of DR’s
ability to extend lifespan. The ability of DR to delay the
age-dependent decline in locomotor activity was also
diminished in daf-16 mutant worms (Figure 3B), indicat-
ing that DAF-16 is necessary for the ability of DR to pre-
vent the age-dependent decline in fitness.
FOXO’s role in sDR-induced increase in lifespan may
be dependent on the insulin signaling pathway, a well-
known regulator of FOXO activity and a sensor of food
levels [17, 18]. To test this possibility, we asked whether
the insulin receptor daf-2 also mediated the beneficial
effects of sDR. In contrast to aak-2 and daf-16, the
long lifespan of daf-2 insulin receptor mutants was fur-
ther extended by sDR (Figure 3C; Table S4B), suggest-
ing that sDR may regulate DAF-16 in a manner that is
not dependent on the insulin receptor pathway. How-
ever, because the daf-2 mutation is not a null mutation,
it is still possible that part of the sDR-induced increase in
lifespan might depend on the insulin receptor pathway.
Several known regulators of FOXO/DAF-16, including
mutation in the insulin receptor or complete starvation,
trigger the nuclear localization of FOXO/DAF-16 [30].
We therefore examined whether sDR triggers nuclear
localization of DAF-16. Unlike starvation, sDR did not
stimulate DAF-16 translocation to the nucleus (Fig-
ure 3D). Taken together, these results indicate that
sDR regulates DAF-16 in a way that is distinct from star-
vation or mutation in the insulin receptor. These obser-
vations suggest that FOXO/DAF-16 may be regulated
by AMPK in response to sDR.
FOXO/DAF-16 Mediates the Ability of AMPK to
Induce Stress Resistance and Longevity in Worms
AMPK function in worms was previously suggested to
be independent of FOXO/DAF-16 [15], but the impor-
tance of FOXO as a mediator of AMPK action on lifespan
has not been directly addressed. To test the possibility
that FOXO/DAF-16 might mediate AMPK’s role in con-
trolling lifespan, we generated transgenic worms ex-
pressing a constitutively active (CA) mutant of worm
AMPK g2 (R81Q). The corresponding mutation in the
AMP binding pocket of AMPK g2 in humans causes
the constitutive activation of AMPK [31]. To determine
whether CA AMPK g2 was sufficient to promote organ-
ismal resistance to oxidative stress, a phenotype tightly
associated with increase in lifespan, we performed oxi-
dative stress resistance assays, via the ROS generator
Paraquat. Three independent CA AMPK g2 transgenic
worm lines (CA 1-3) were more resistant than control
worm lines (EV 1-3) to increasing concentrations of
Paraquat (Figure 4A) or to increasing times of treatment
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(A) Description of our dietary restriction method (sDR) inC. elegans. Populations of worms obtained by synchronized egg laying (EL) were scored
and switched to freshly seeded plates every other day (indicated by asterisk). sDR was initiated at day 4 of adulthood. AL, ad libitum.
(B) Representative pictures of worms fed different concentrations of bacteria expressing DsRed, a red fluorescent protein. Right: quantification
of DsRed fluorescence of wild-type (N2) worms incubated with different bacterial dilutions. Results represent the average and SEM of 3
independent experiments performed with 30 worms per condition at day 7. ***p < 0.001 in one-way ANOVA. AL, 5 3 1011 bacteria/ml; sDR,
5 3 108 bacteria/ml.
(C) Serial dilution of OP50-1 bacteria increases worm lifespan (53 108 bacteria/ml = 28.9% increase over 53 1011 bacteria/ml). Mean and stan-
dard errors for this experiment done in triplicate are presented in Table S1.
(D) Gompertz analysis shows that sDR (5 3 108 bacteria/ml) decreases the worm mortality rate.
(E) sDR-treated worms displayed a 36% increase in survival compared with AL-fed worms at 200 mM Paraquat (p < 0.0001). The mean and SEM
for duplicate experiments done in sextuplicate is presented in Table S2A.
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(A) The AMP:ATP ratio, measured by reverse-phase HPLC, increases when worms are dietarily restricted at day 7. The results presented are the
mean and SEM of two independent experiments of 5 samples each. **p = 0.0079 by Mann-Whitney test.
(B) AMPK mediates sDR’s ability to extend lifespan. aak-2mutant worms displayed a mild decrease in lifespan compared to WT (N2) worms in ad
libitum (AL) conditions (5 3 1011 bacteria/ml) (10.5%; p < 0.0001). Under sDR conditions (5 3 108 bacteria/ml), aak-2 mutant worms had a 48%
shorter lifespan compared to WT (N2) worms (p < 0.0001). Comparison of five independent experiments performed in triplicate is presented in
Table S3.
(C) sDR delays the age-dependent decline in locomotor activity in an aak-2-dependent manner. The experiment was performed as described in
the legend of Figure 1F. *p < 0.05; **p < 0.01; ***p < 0.001 in one-way ANOVA. Note that N2 worms are also represented in Figure 1F.with Paraquat (Figure 4B; Table S5A). The stress protec-
tive effects of CA AMPK g2 were reverted in worms in
which daf-16 was knocked-down by RNAi (Figures 4C
and 4D; Table S5A), indicating that the ability of this con-
stitutive form of AMPK to induce stress resistance is
DAF-16 dependent.
To examine whether DAF-16 was also required for
AMPK’s ability to regulate lifespan, we examined the
lifespan of CA AMPK g2 transgenic worms in the
absence or presence of daf-16. Consistent with the pre-
vious finding that AAK-2 (AMPK a2) overexpression
slightly extends worm lifespan [15], two independent
CA AMPK g2 transgenic lines (CA2 and CA3) displayed
a modest, but statistically significant, increase in life-
span (Figure 4E; Table S5B). The increased longevity
of CA AMPK g2 transgenic worms (CA3) was reverted
when DAF-16 expression was inhibited by RNAi (Fig-
ure 4F; Table S5B), indicating that AMPK’s ability to ex-
tend lifespan requires DAF-16. Together, these results
show that the worm FOXO factor DAF-16 is necessary
to mediate the effects of AMPK on oxidative stress resis-
tance and longevity.
AMPK Activates FOXO/DAF-16-Dependent
Transcription
To gain insight into the mechanism of AMPK’s action on
FOXO/DAF-16 transcription factor, we examined the ef-
fect of AMPK activity on the expression of sod-3,
a known DAF-16 target gene involved in both stress re-
sistance and longevity [20, 32]. By using quantitative
RT-PCR, we found that sod-3 mRNA was increased
in worms expressing the constitutively active form of
AMPK (CA3) compared to control worms (EV1) and
that this increase was dependent on the expression of
DAF-16 (Figure 5A). Consistent with this observation,sod-3 mRNA expression was also decreased in AMPK
a2 (aak-2) mutant worms compared to wild-type worms
(Figure 5B). These findings support the notion that
AMPK enhances the ability of DAF-16 to transactivate
sod-3.
AMPK Directly Phosphorylates DAF-16 In Vitro
AMPK could regulate FOXO/DAF-16 activity indirectly,
via the insulin receptor, or directly, via phosphorylation.
Given that sDR’s beneficial effects on longevity appear
to be independent of the insulin receptor, we asked
whether AMPK could directly phosphorylate FOXO/
DAF-16. To this end, we performed in vitro kinase as-
says with purified AMPK and a bacterially expressed
form of DAF-16 as a substrate. We found that both
worm and human AMPK phosphorylated worm DAF-16
(Figure 6A). DAF-16 phosphorylation by AMPK was
greatly enhanced by the presence of AMP (Figure 6A),
confirming that the purified kinase responsible for
DAF-16 phosphorylation is AMP dependent. The stoi-
chiometry of phosphorylation of DAF-16 by human and
worm AMPK was higher than that of the SAMS peptide,
a peptide containing a known AMPK phosphorylation
site [13] (Figure 6B), suggesting that DAF-16 is a good
in vitro substrate of AMPK.
We sought to determine the residues of FOXO/DAF-16
that were phosphorylated by AMPK. By using a combi-
nation of tandem mass spectrometry and site-directed
mutagenesis, we found that AMPK phosphorylated
DAF-16 in vitro at least at six residues—T166, S202,
S314, S321, T463, and S466—that conform to varying
degrees to the consensus motif phosphorylated by
AMPK (amphipathic helix-bfXbXXS/TXXbf; f, hydro-
phobic residues; b, basic residues) [33] (Figure 6C).
The concomitant mutation of T166, S314, and S466(F) sDR delays the age-dependent decline in worm locomotor activity. Quantification of the length of worm tracks after 1 hr on fresh ad libitum
lawns of OP50-1 bacteria was performed with Image J. Each point represents the average movement and SEM of at least 20 worms. *p < 0.05;
**p < 0.01; ***p < 0.001 in one-way ANOVA.
(G) sDR induced by dilution of UV-killed bacteria results in a 15.9% increase in lifespan of N2 worms (statistically different from
ad libitum fed worms with a p = 0.0004). The mean and SEM of two independent experiments conducted in triplicate is presented in
Table S2B.
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(A) DAF-16 is necessary for sDR to extend lifespan. sDR leads to a 30.6% increase (p < 0.0001) in longevity in wild-type (N2) worms but does not
significantly affect the lifespan of daf-16 mutant worms. The mean and SEM of three independent experiments conducted in triplicates of
30 worms each is presented in Table S4A.
(B) sDR delays the age-dependent decline in locomotor activity in a daf-16-dependent manner. The experiment was performed as described in
the legend of Figure 1F. *p < 0.05; **p < 0.01; ***p < 0.001 in one-way ANOVA. Note that N2 worms are also represented in Figure 1F.
(C) sDR is not dependent on the insulin receptor daf-2. sDR induced a 35.2% increase (p < 0.0001) in wild-type (N2) worms and a 31.0% increase
(p < 0.0001) in daf-2 mutant worms whereas sDR did not increase the lifespan of aak-2 mutant worms. The mean and SEM of two independent
experiments conducted in triplicates of 30 worms each is presented in Table S4B.
(D) sDR does not cause DAF-16 nuclear localization. DAF16:GFP-expressing worms were placed on ad libitum or sDR diet for 6 hr at day 7 of life.significantly reduced the phosphorylation of DAF-16 by
AMPK, indicating that these three sites are the main
residues phosphorylated by AMPK in vitro (Figure 6D).
The replacement of all six residues (T166, S202, S314,
S321, T463, and S466) by alanine further reduced the
phosphorylation of DAF-16 by AMPK, suggesting that
S202, S321, and T463 are also phosphorylated by
AMPK (Figure 6D). Taken together with our experiments
on the effect of AMPK on sod-3, these findings suggest
that AMPK could activate FOXO/DAF-16-dependent
transcription via direct phosphorylation at these previ-
ously unidentified sites. However, our results do not ex-
clude the possibility that AMPK may also regulate FOXO/
DAF-16 indirectly. We have recently found that AMPK
phosphorylates the human FOXO transcription factor
FOXO3 at multiple sites in vitro and in cells [34], raising
the possibility that the direct connection between AMPK
and FOXO may be conserved throughout evolution.
Discussion
sDR: A Novel Method of DR that Extends Lifespan
in Worms
We have developed a novel method of dietary restriction
in C. elegans that we termed sDR. sDR has hallmarks ofdietary restriction in many species in that it (1) reduces
food intake; (2) reproducibly extends lifespan; (3) delays
the age-dependent decline in physical fitness; and (4)
induces resistance to oxidative stress. Another well-
known hallmark of dietary restriction is a reduction in
fertility. sDR is initiated at day 4 of adulthood, which is
past the reproductive period in worms. We found that
if sDR was initiated earlier, it indeed reduced fertility,
but also had deleterious effects on survival (E.L.G. and
A.B., unpublished data). The fact that sDR extends life-
span at a postreproductive age suggests that sDR ex-
tends lifespan independently of changes in fertility.
The other methods that have been used in C. elegans
to induce or mimic DR include the eat-2 mutation, which
reduces pharyngeal pumping [29], the dilution of feeding
bacteria in liquid culture (bDR or lDR) [26–28, 35], the to-
tal absence of bacteria in liquid culture (axenic medium)
[26], a chemically defined liquid media [36], the dilution
of peptone in the plates [37], and the total absence of
food on plates (DD for dietary deprivation) [24, 25] (Fig-
ure 7). Compared to these other methods, sDR is rela-
tively simple to implement because it is done in the me-
dium commonly used for worms in the laboratory and it
can be performed with any mutant strain of worm. sDR is
also similar to regimens used in other species, including
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(A) Constitutively active (CA) AMPK g2 transgenic worms display an increased resistance to increasing concentrations of the reactive oxygen
species generator Paraquat compared to control transgenic worms injected with an empty vector (EV) after 7 hr of incubation. Three independent
lines of EV (1-3) and CA (1-3) were analyzed.
(B) CA3 displayed an 86.0% increased resistance to 300 mM Paraquat over control EV1 (p < 0.0001). The mean and SEM of two independent
experiments conducted in sextuplicate is presented in Table S5A.
(C) Stress resistance of CA AMPK g2 transgenic worms is dependent on the presence of DAF-16. CA3 worms were fed bacteria expressing RNAi
to daf-16 or control bacteria (ctl) and submitted to increased concentrations of Paraquat for 8 hr.
(D) CA3 displayed a 48.9% increased stress resistance compared to EV1 (p = 0.0005) but did not significantly increase stress resistance when
treated with RNAi to daf-16. The mean and SEM of two independent experiments conducted in sextuplicate is presented in Table S5A.
(E) CA AMPK g2 transgenic worms (CA2 and CA3) displayed a statistically significant increase in median lifespan (9.5% and 17.7%, respectively,
p < 0.001) compared to EV1 control worms. A comparison experiment done in triplicate is presented in Table S5B.
(F) CA AMPK g2 lifespan extension is DAF-16 dependent. CA AMPK g2 transgenic worms (CA3) show a statistically significant increase in median
lifespan (11%; p = 0.0006) compared to control transgenic worms (EV1) but did not display a significantly lifespan extension compared to EV1
when treated with RNAi to DAF-16. Comparison of two independent experiments done in triplicate is presented in Table S5B.mammals, in which DR is achieved by a reduction of the
food normally provided to the animals.
sDR Reveals the Importance of AMPK and FOXO
in Dietary Restriction-Induced Longevity
Our findings suggest the following sequence of events.
sDR activates AMPK by increasing the AMP:ATP ratio.
Activated AMPK enhances FOXO/DAF-16-dependent
transcription, perhaps via direct phosphorylation, lead-
ing to resistance to oxidative stress and longevityextension (Figure 7). The finding that sDR’s ability to ex-
tend lifespan is dependent on the presence of AMPK/
AAK-2 and FOXO/DAF16 is in contrast to numerous
studies in worms that indicate that aak-2 and daf-16
do not mediate the lifespan extension observed in eat-
2 mutant [16, 29] and that daf-16 does not mediate the
lifespan extension by lDR [27], axenic medium [26], DD
[24, 25], or bDR, particularly when bacteria are diluted
less than 10-fold from ad libitum conditions [26, 28].
However, our results are consistent with the observation
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resulted in the upregulation of daf-16 and daf-16-depen-
dent gene expression [36] and the observation that the
lifespan extension by bDR when bacteria are diluted
more than 10-fold from ad libitum conditions shows
a partial daf-16 dependency [26, 28].
One possible interpretation of these contradictory
findings is that various methods of DR elicit distinct sig-
naling pathways because they restrict food intake in
different manners. For example, the degree of food re-
striction and whether food restriction is chronic or acute
could influence the mechanisms underlying longevity
caused by DR. eat-2 mutants, which have a germline
mutation in the acetylcholine receptor that reduces their
pharyngeal pumping rate, likely induce a form of DR that
is chronic [38], whereas sDR, by diluting the bacteria
1000-fold at a specific adult stage, may elicit a more
acute form of DR. Different DR methods may also alter
proteins, carbohydrates, or lipids in different propor-
tions, which may engage distinct mechanisms of nutri-
ent sensing.
The differences in the mechanisms relaying sDR ver-
sus other liquid DR regimens may also be due to other
Figure 5. AMPK Activates FOXO/DAF-16-Dependent Transcription
of sod-3
(A) sod-3mRNA is increased in CA AMPK g2 transgenic worms (CA3)
compared with empty vector control transgenic line (EV1), and this
increase is daf-16 dependent. The results presented correspond
to the mean and SEM of three independent quantitative RT-PCR
experiments. *p < 0.05; **p < 0.01; ***p < 0.001 in a one-way ANOVA
statistical test.
(B) sod-3 mRNA was decreased in aak-2 mutant worms compared
with N2 wild-type worms. The results presented correspond to the
mean and SEM of two independent experiments: *p < 0.05 in a paired
t test.parameters that differ between these two methods, in-
cluding movement, energy expenditure, food sensing,
oxygen levels, bacterial amounts, or osmotic conditions.
Finally, some DR regimens may also extend lifespan by
reducing some kind of food-related toxicity. However,
sDR is unlikely to operate solely via reduced food toxic-
ity, because an excess of bacteria is not detrimental
for lifespan and because a dilution of UV-killed bacteria
also extends lifespan. Dissecting the mechanisms by
which different methods of DR extend lifespan and un-
derstanding the parameters that vary between the DR
regimens will be important for designing efficient inter-
ventions to extend lifespan.
Molecular Mechanisms Mediating DR in Worms
Interestingly, recent evidence indicates that the ability of
eat-2 mutants and bDR to extend lifespan is mediated
by a member of the Forkhead family, the FOXA/PHA-4
transcription factor [28]. lDR has also been recently
shown to be sensed specifically in sensory neurons by
the transcription factor SKN-1 [27]. Finally, the sir-2
gene has been shown to be important to mediate certain
forms of DR in a variety of species from yeast to flies [39–
42], though this observation is still subject to debate [24,
25, 43, 44]. SIR-2, an NAD-dependent protein deacety-
lase, may sense dietary restriction signals via alterations
of the NAD:NADH ratio whereas AMPK may sense DR
through changes in the AMP:ATP ratio. It will be interest-
ing to determine whether SIR-2, PHA-4, and SKN-1 are
important to mediate lifespan extension by sDR. Uncov-
ering the genetic interactions between the SIR-2, the
AMPK-FOXO, the FOXA, and the SKN-1 pathways will
give important insight into the network of longevity
regulation by DR (Figure 7).
AMPK Increases Lifespan and Stress Resistance
via FOXO-Dependent and FOXO-Independent
Mechanisms
We have shown that AMPK regulates lifespan in a daf-
16-dependent manner. However, Apfeld et al. reported
that mutating one of the AMPK catalytic subunits, aak-2,
in conjunction with mutating daf-16 decreased worm
lifespan further than mutating each gene individually
[15]. This experiment raises the possibility that DAF-16
may not be the sole contributor of AMPK’s effect on life-
span. AMPK is known to regulate the TOR pathway in
mammals [45], and mTOR/LET-363 and S6 kinase muta-
tions have been found to extend lifespan in yeast,
worms, and flies [44, 46–49]. Thus, the mTOR-S6 kinase
pathway may also mediate part of AMPK’s ability to
extend lifespan (Figure 7). Changes in transcription (via
FOXO) and translation (via TOR) may be both orches-
trated by AMPK to allow the organism to adapt its lon-
gevity to low energy levels. Lastly, AMPK may also reg-
ulate the other proteins recently identified as important
mediators of DR, including SIR-2, PHA-4, and SKN-1.
AMPK Phosphorylation of DAF-16: A Mechanism
of Regulation?
The direct phosphorylation of DAF-16 by AMPK may be
one of the mechanisms by which DR regulates longevity
in worms. DAF-16 is phosphorylated by AMPK at multi-
ple novel sites that are located in the DNA binding
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(A) AMPK phosphorylates DAF-16 in an AMP-dependent manner. Results with human AMPK are presented, but both human and worm AMPK
phosphorylate DAF-16 in an AMP-dependent manner.
(B) Stoichiometry of phosphorylation of DAF-16 by human AMPK. The graph represents the mean and standard deviation of normalized molar
units of phosphate incorporated per mole of substrate of 3 independent experiments. Similar results were obtained with the worm AMPK.
(C) Schematic of DAF-16 showing the location of the residues of DAF-16 phosphorylated by AMPK in vitro. DBD, DNA-binding domain. Alignment
of the AMPK consensus phosphorylation motif with phosphorylation sites in DAF-16. f, hydrophobic residues; b, basic residues. The sequence
in parentheses represents an amphipathic helix. The sites in italics were identified as being phosphorylated in vitro by AMPK by tandem mass
spectrometry. All the sites listed here were confirmed as being phosphorylated in vitro by AMPK by site-directed mutagenesis.
(D) DAF-16 mutants display a significant reduction in phosphorylation by AMPK compared to WT DAF-16 in an in vitro kinase assay. 3A, T166A/
S314A/ S466A mutant; 6A, T166A/S202A/S314A/S321A/T463A/S466A.domain and the C-terminal transactivation domain, and
these sites differ from AKT phosphorylation sites. There-
fore, AMPK may regulate DAF-16 independently of its
subcellular localization, consistent with our observation
that sDR, which activates AMPK, does not stimulate
DAF-16 nuclear translocation. Our experiments do not
rule out, however, the possibility that AMPK regulates
DAF-16 via an indirect mechanism or that AMPK and
DAF-16 act in different tissues to regulate longevity in
response to DR.
An AMPK-FOXO Pathway in Other Species
Whether AMPK and FOXO play a role in DR-induced lon-
gevity in other species is not known. We have recently
found that AMPK phosphorylates human FOXO3 in
mammalian cells at novel regulatory sites that are dis-
tinct from the AKT sites [34]. Similar to our results in
worms, AMPK also activates FOXO3-dependent tran-
scription in mammalian cells [34], raising the possibility
that the mechanism of regulation of FOXO by AMPK may
be conserved.
A number of compounds that activate AMPK, includ-
ing metformin, phenformin, and resveratrol, have been
proposed to act as potential ‘‘caloric restriction mi-
metics’’ in mammals [50, 51]. It will be interesting to
test whether these compounds affect lifespan in an
AMPK-dependent manner. Understanding the mecha-
nisms underlying the conserved extension of lifespan
by DR will help harness the power of this intervention
to slow aging and the onset of age-related diseases.Experimental Procedures
Worm Strains and RNA Interference
N2 and daf-16 (mu86) strains were a kind gift from M.-W. Tan. The
zIs356 IV (TJ356) (daf-16:GFP strain) was a kind gift from T. Johnson.
The aak-2 (ok524) and daf-2 (e1370) strains were generously pro-
vided by T. Stiernagle at the Caenorhabditis Genetics Center.
HT115 (DE3) bacteria transformed with vectors expressing dsRNA
of the genes of interest were obtained from the Ahringer library (a
gift from M.-W. Tan) and were grown at 37C and seeded onto stan-
dard nematode growth medium (NGM) plates [52] containing ampi-
cillin (100 mg/ml) and IPTG (0.4 mM). Adult worms were placed on
these plates and removed after 4–6 hr to obtain synchronized
populations of worms. Each vector was sequenced to verify the
presence of the appropriate gene of interest.
Worm Transgenic Lines
The PRKAG2 (AMPKg2) gene (WBGene00020633/WP:CE29350) and
regulatory regions were amplified by PCR from wild-type N2 worm
genomic DNA and was subcloned into the L3691 pPD117.01 vector
(a kind gift from A. Fire). To generate a constitutively active mutant,
we replaced Arg81 by Glu (R81Q mutant) [31] by site-directed muta-
genesis. Purified plasmids of interest (the L3691 vector without the
coding region of AMPKg2, L3691 vector encoding WT AMPKg2, or
L3691 vector encoding the R81Q mutant of AMPKg2) were coin-
jected with pha-1 encoding plasmid into pha-1 mutant worms.
Worms were placed at 24C after injection and were allowed to lay
eggs to rescue the pha-1 phenotype. Individual F1 strains were se-
lected from various injections and were clonally expanded. Incorpo-
ration of extrachromosomal arrays was verified by PCR of genomic
DNA isolated from worms.
Lifespan in C. elegans
Worm lifespan assays were performed at 20C. Worm populations
were synchronized by placing young adult worms on NGM plates
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1654Figure 7. Proposed Model for the Molecular Networks Integrating Different DR Methods
Different methods of dietary restriction may activate distinct signaling pathways or activate them to varying degrees. The table below the figure
summarizes which pathways have been tested. The red question mark indicates an interaction identified in mammals, but not yet confirmed in
C. elegans. sDR, solid plate DR; bDR, liquid DR described in [28, 35]; lDR, liquid DR described in [27]; DD, dietary deprivation [24, 25]; axenic,
absence of bacteria in liquid culture [26]; peptone, dilution of peptone in plates [37]; CDLM, chemically defined liquid media [36]. D, dependency;
I, independency; D/I?, dependency or independency based on different reports in the literature [42, 44, 53]; NT, not tested. Single asterisk: note
that the lifespan extension by bDR when bacteria are diluted more than 10-fold from ad libitum conditions shows a partialdaf-16dependency [26,
28]. Double asterisk: note that the daf-2mutation is not a null mutation, which could affect the interpretation of the results. clk-1, mutant of a gene
necessary for ubiquinone biosynthesis [29].seeded with the E. coli strain OP50-1 (unless otherwise noted) for 4–
6 hr and then removed. The hatching day was counted as day one for
all lifespan measurements. Worms were changed every other day to
new plates to eliminate confounding progeny and were marked as
dead or alive. Worms were scored as dead if they did not respond
to repeated prods with a platinum pick. Worms were censored if
they crawled off the plate or died from vulval bursting. For each life-
span assay, 90 worms were used in 3 plates (30 worms/plate). The
data were plotted with the Kaplan-Meier Survival curves, and statis-
tical significance was determined by Logrank (Mantel-Cox) tests.
Lifespan assays were repeated at least once and showed similar
trends in relative lifespan effects. Representative Kaplan-Meier sur-
vival curves are shown in the figures. Means, SEM, and p values are
shown in Tables S1–S5.
Dietary Restriction in C. elegans
OP50-1 bacteria were serially diluted from 5 3 1012 bacteria/ml to
5 3 104 bacteria/ml. Bacteria were resuspended in S Medium to in-
hibit bacterial growth. 150 ml of these solutions were plated on each
35 mm plate on the day of transfer. 30 adult worms were placed on
each plate containing various concentrations of bacteria starting at
day 7 of life (day 4 of adulthood). Worms were switched to freshplates every other day. Worms placed on bacterial concentrations
ranging from 5 3 104 bacteria/ml to 5 3 107 bacteria/ml died within
2 days after being placed on these extreme dietary restriction diets.
Dietary restriction (sDR) was considered 53 108 bacteria/ml and ad
libitum (AL) was 5 3 1011 bacteria/ml. OP50-1 grown to saturation
overnight normally resulted in a concentration of bacteria of 5 3
1011 bacteria/ml. The lifespan assays were conducted in the ab-
sence of FUDR. For lifespan experiments with UV-killed bacteria,
OP50-1 bacteria were UV-irradiated for 4 min in a UV Stratalinker
2400 (0.6 Joules). This type of UV treatment completely prevented
bacterial growth in solid and liquid cultures.
AMP:ATP Ratio Quantification
100 day 7 hand-picked C. elegans were placed in ad libitum or sDR
conditions for 12 hr under the same conditions as for lifespan as-
says. Worms were then picked onto bacteria-free plates, pooled,
and washed twice with M9 buffer (KH2PO4, 22 mM; K2HPO4,
34 mM; NaCl, 86 mM; MgSO4, 1 mM). All but 20 ml of M9 buffer
was removed from worm pellet. 80 ml of ice-cold 8% (v/v) perchloric
acid was added to worm samples. The samples were then sonicated
and 1N KHCO3 was added to neutralize perchloric acid. The samples
were briefly centrifuged and supernatants were filtered through
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1655a .22 mm filter, and then reverse-phase HPLC was performed on a
LC-18 250 3 4.6 mm 5 mm column. Samples were separated by ad-
dition of buffer A (KH2PO4 [pH 6.0], 0.1 M). Nucleotides were de-
tected at 254 nm with a Varian Pro Star detector. Peak areas were
measured with Varian Star Workstation software. Nucleotide identi-
ties were confirmed by comigration with AMP and ATP standards
(Sigma).
AMPK In Vitro Kinase Assay
Purified AMPK (Upstate Biotechnology or purified from 293T cells)
was incubated with various substrates (1 mg) in the kinase reaction
buffer (HEPES [pH 7.0], 15 mM; DTT, 450 mM; MgCl2, 18.75 mM;
b-glycero-phosphate, 6.25 mM; EGTA, 1.25 mM; ATP, 125 mM) and
12.5 mCi radiolabeled ATP, with or without 150 mM AMP, at 30C
for 15 min. Phosphorylation was detected by incorporation of radio-
labeled [g-32P]ATP. Quantifications were performed with the Amer-
sham Storm phospho-imager and the Image Quant 5.2 software.
The stoichiometry of phosphorylation was measured by excising
Coomassie-stained bands of substrate and by quantifying the
amount of radioactivity incorporated with a scintillation counter.
The molar incorporation of phosphate was calculated and was
divided by the molar amount of substrate. To compare independent
experiments, the average moles of phosphate/molar amount of
substrate was used to normalize the data.
Liquid Chromatography Followed by Tandem
Mass Spectrometry
A Coomassie-stained band corresponding to GST-DAF-16 phos-
phorylated by AMPK was excised from an SDS-PAGE gel, divided
in half, reduced with DTT, alkylated with iodoacetamide, and di-
gested with either trypsin or chymotrypsin. Peptide mixtures were
separated by microcapillary reverse-phase chromatography and
online analyzed in a hybrid linear ion trap-orbitrap (LTQ-Orbitrap,
Thermo Electron) mass spectrometer. Mass spectra were database
searched with the SEQUEST algorithm. All peptide matches were
initially filtered based on enzyme specificity, mass measurement
error, and Xcorr and DCorr’ scores and further manually validated
for peptide identification and site localization.
Worm RNA Extraction and Reverse Transcription
Followed by Quantitative PCR
RNA was extracted by addition of 1 ml of Trizol (Invitrogen) for 100 ml
of worm pellet, followed by six freeze-thaw cycles in liquid nitrogen.
The RNA extraction was performed according to the Trizol protocol.
The expression of sod-3 was determined by reverse transcription of
1 mg total RNA with the Superscript II kit (Invitrogen) followed by
quantitative PCR analysis on a Bio-rad iCycler with iQ SYBR green
(Bio-rad) with the following primers: sod-3 F: CAACTTGGCTAAG
GATGGTGGAG; sod-3R: GCATTGGCAAATCTCTCGCTG; pan-actin
F: TCGGTATGGGACAGAAGGAC; pan-actin R: CATCCCAGTTGGT
GACGATA.
The experiments were conducted in triplicate and the results were
expressed as 2(2(Gene of interest number of cycles 2 actin number of cycles)).
Control PCR reactions were also performed on total RNA that had
not been reverse-transcribed to test for the presence of genomic
DNA in the RNA preparation.
Constructs, oxidative stress resistance in worms, quantification of
bacterial ingestion with DsRed, DAF-16 localization assays, worm
locomotor activity, and worm and human AMPK purification were
performed as described in detail in the Supplemental Experimental
Procedures.
Supplemental Data
Four tables and Experimental Procedures are available at http://
www.current-biology.com/cgi/content/full/17/19/1646/DC1/.
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